arXiv:2601.00581v3 Announce Type: replace-cross
Abstract: We introduce AceFF, a pre-trained machine learning interatomic potential (MLIP) optimized for small molecule drug discovery. While MLIPs have...
By Stephen E. Farr, Stefan Doerr, Antonio Mirarchi, Alireza Moradzadeh, Francesc Sabanes Zariquiey, Saee Paliwal, Gianni De Fabritiis
arXiv:2506. 14488v2 Announce Type: replace-cross Abstract: Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution.
By Dong Xu, Zhangfan Yang, Junchuang Cai, Sisi Yuan, Zexuan Zhu, Jianqiang Li, Junkai Ji
The paper introduces two closed‑form projection operators that enforce physical validity in biomolecular diffusion models during inference. One operator resolves inter‑chain van der Waals clashes, while the other restores ligand geometry, including bond lengths, angles, planarity, and chirality. These lightweight, model‑agnostic corrections preserve structural accuracy and ligand placement across multiple benchmarks without adding runtime or memory overhead.
By Qurat-ul-ain, Yee Whye Teh, Charlotte M. Deane, Matteo Cagiada
HierDTA is a hierarchical structure‑aware framework for drug–target affinity prediction that represents drugs as atom–motif heterogeneous graphs and proteins as residue interaction graphs. It integrates atom and residue representations via cross‑attention, supplemented by molecule fingerprints and pretrained ESM‑2 embeddings, achieving superior performance on the Davis and KIBA datasets and strong generalization in cold‑start scenarios. Ablation studies and interpretability analyses confirm the contributions of its hierarchical augmentation and interaction components, and case studies demonstrate early enrichment of candidate bioactive compounds.
By Huangchao Xu, Baohua Zhang, Qian Liu, Zhong Jin, Yi Du
arXiv:2606. 23856v1 Announce Type: new Abstract: Generative molecular models for drug design are a promising direction with much active research.
By Konstantin Yatsenko, Arvind Thiagarajan
arXiv:2607. 12349v1 Announce Type: new Abstract: Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design.
By Ruoxi Gao, Jiangweizhi Peng, Ziqi Chen, Frazier N. Baker, David C. Kombo, John L. Kane Jr., Andrew A. Scholte, Yi Li, Matthew J. LaMarche, Luigi I. Iconaru, Hans-Peter Biemann, Mingyi Hong, Xia Ning